CoChat

Atopic dermatitis displays stable and dynamic skin transcriptome signatures

Möbus, Lena, Rodriguez, Elke, Harder, Inken, Stölzl, Dora, Boraczynski, Nicole, Gerdes, Sascha, Kleinheinz, Andreas, Abraham, Susanne, Heratizadeh, Annice, Handrick, Christiane, Haufe, Eva, Werfel, Thomas, Schmitt, Jochen, Weidinger, Stephan · 2021 · Journal of Allergy and Clinical Immunology
Cited by 133

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

BACKGROUND Skin transcriptome studies in atopic dermatitis (AD) showed broad dysregulation as well as "improvement" under therapy. These observations were mainly made in trials and based on microarray data. OBJECTIVES To explore the skin transcriptome and the impact of systemic treatment in patients of the TREATgermany registry. METHODS Biopsies from 59 patients with moderate to severe AD before and 30 patients 12 weeks after start of systemic treatment (dupilumab n=22, cyclosporine n=8), and from 31 healthy controls were subjected to mRNA sequencing. Differential expression, pathway enrichment, correlation, and co-expression network analysis were conducted. RESULTS Both lesional and non-lesional skin showed a stable "core" signature characterised by disturbed epidermal differentiation and activation of IL31-IL1 signalling. A second dynamic signature showed progressive enrichment for type 2 inflammation, type 17 signalling and NK cell function. Markers correlated with disease activity have functions in epidermal barrier properties and immune modulation. IL4RA was among the top 3 central dysregulated genes. Cyclosporine led to a more pronounced global transcriptome reversion and normalised Th17/IL23 signalling, whereas dupilumab led to a stronger increase of epidermal differentiation markers. Both treatments strongly decreased type 2 markers, but overall the residual profile was still profoundly different from healthy skin. Lower IL4RA and IL13, and high IL36A expression were related to a stronger clinical response to dupilumab. CONCLUSION The AD core signature is characterised by dysregulation of genes related to keratinocyte differentiation and itch signalling. A dynamic signature reflects progressive immune responses dominated by type-2 cytokines with an additional role of type 17 and NK cell signalling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2020.06.012

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Möbus, L., Rodriguez, E., Harder, I., Stölzl, D., Boraczynski, N., Gerdes, S., Kleinheinz, A., Abraham, S., Heratizadeh, A., Handrick, C., Haufe, E., Werfel, T., Schmitt, J., & Weidinger, S.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2021-01
Volume
147
Issue
1
Pages
213-223
ISSN
0091-6749 (ISSN-L)
OpenAlex
W3039654485
Cited by
133
References
13
FWCI
11.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.